Vertex Pharmaceuticals (VRTX) Shareholder's Equity Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.37% |
| Dec 31, 2025 | 13.75% |
| Sep 30, 2025 | 10.80% |
| Jun 30, 2025 | 16.25% |
| Mar 31, 2025 | -11.05% |
| Dec 31, 2024 | -6.66% |
| Sep 30, 2024 | -5.34% |
| Jun 30, 2024 | -4.50% |
| Mar 31, 2024 | 28.51% |
| Dec 31, 2023 | 26.36% |
| Sep 30, 2023 | 26.73% |
| Jun 30, 2023 | 29.64% |
| Mar 31, 2023 | 32.32% |
| Dec 31, 2022 | 37.75% |
| Sep 30, 2022 | 36.71% |
| Jun 30, 2022 | 29.76% |
| Mar 31, 2022 | 21.45% |
| Dec 31, 2021 | 16.27% |
| Sep 30, 2021 | 17.18% |
| Jun 30, 2021 | 22.30% |
| Mar 31, 2021 | 38.98% |
| Dec 31, 2020 | 42.75% |
| Sep 30, 2020 | 54.82% |
| Jun 30, 2020 | 48.31% |
| Mar 31, 2020 | 36.80% |
| Dec 31, 2019 | 37.20% |
| Sep 30, 2019 | 79.02% |
| Jun 30, 2019 | 86.75% |
| Mar 31, 2019 | 94.31% |
| Dec 31, 2018 | 117.17% |
| Sep 30, 2018 | 62.73% |
| Jun 30, 2018 | 45.40% |
| Mar 31, 2018 | 44.45% |
| Dec 31, 2017 | 52.62% |
| Sep 30, 2017 | 49.23% |
| Jun 30, 2017 | 59.75% |
| Mar 31, 2017 | 50.76% |
| Dec 31, 2016 | 22.36% |
| Sep 30, 2016 | 12.22% |
| Jun 30, 2016 | 11.51% |
| Mar 31, 2016 | 11.90% |
| Dec 31, 2015 | -0.23% |
| Sep 30, 2015 | -6.85% |
| Jun 30, 2015 | -10.58% |
| Mar 31, 2015 | -18.96% |
| Dec 31, 2014 | -19.18% |
| Sep 30, 2014 | -20.12% |
| Jun 30, 2014 | -22.34% |
| Mar 31, 2014 | 31.23% |
| Dec 31, 2013 | 13.43% |
| Sep 30, 2013 | 17.99% |
| Jun 30, 2013 | 25.19% |
| Mar 31, 2013 | -12.18% |
| Dec 31, 2012 | 28.80% |
| Sep 30, 2012 | 76.68% |
| Mar 31, 2012 | 172.70% |
| Dec 31, 2011 | 84.23% |
| Sep 30, 2011 | 6.78% |
| Mar 31, 2011 | -60.46% |
| Dec 31, 2010 | -54.03% |